Searched for
GYNAECOLOGY SEGMENT
Cloudnine's 25% stake sale attracts top global PE firmsLeading global private equity firms are in the running to acquire a substantial minority stake in Cloudnine, India's premier maternity and ...- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%, according to analystsThis is easy to say, but difficult to actually implement: As an investor, make a distinction between the day-to-day movement of indices and...
- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
- US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore dealUS private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is ...
- Warburg Pincus talks in final lap to buy Integrace Health for Rs 1,200 croreIntegrace is currently owned by homegrown PE fund True North and Singapore sovereign investor Temasek Holdings. True North Fund VI LLP hold...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- India's pharma market grows 8% in '22 led by price hikesIn 2021, the market had shown a growth of 14.9%, primarily because of a low base, and the high volume offtake of Covid-19 and related medic...
- Global private equity funds in talks to purchase minority stake in BDR PharmaceuticalsFunds like the Carlyle Group, Warburg Pincus and TA Associates are engaged in initial discussions, the people added. Investment bank O3 Cap...
- Shield Healthcare acquires two entities for undisclosed sumFollowing the acquisitions, Shield Healthcare aims to increase its presence in gynaecology and paediatrics, a company release said here on ...
- Novartis divests anti-infectives brands to Samara CapitalThe portfolio of brands acquired focus on anti-infectives largely catering to the women's health and gynaecology segment, the spokesperson ...
- Torrent completes acquisition of Novartis brandsLast month, Torrent had announced inking of pacts with Novartis AG to acquire the two brands.Torrent Pharma shares today ended 0.27 per cen...
- Brinton raises $4 million from Tata Capital"Our plan is to enter into paediatric and gynaecology (segments).The funding will be used to enter these two areas. We will be adding 200 p...
- Demonetisation: Use of old notes ups sales of key medicinesRetailers say people used old Rs 500 and Rs 1000 notes to buy such medicines which are used regularly and hence their stocks can be used fo...
- Sanofi Aventis plans to buy Generics, OTC brandsIt was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...
- Lupin enters gynaecology segmentDrug major Lupin on Wednesday said its domestic business will continue to focus on lifestyle segment and it has entered the gynaecology seg...
Load More
